Quarterly report pursuant to Section 13 or 15(d)

Loss Per Share of Common Stock - Anti-dilutive Securities (Details)

v3.23.3
Loss Per Share of Common Stock - Anti-dilutive Securities (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 442,803 151,020 442,803 151,020
Common shares underlying convertible debt        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 980,673 22,644 980,673 22,644
Warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 3,280,940 544,753 3,280,940 544,753
Unvested restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) 843,110 16,000 843,110 16,000